DOI: 10.5281/zenodo.11103522
title: MultiCardioNER Corpus: Multilingual Adaptation of Clinical NER Systems to the Cardiology Domain

description: MultiCardioNER

MultiCardioNER is a shared task about the adaptation of clinical NER systems to the cardiology domain. It uses a combination of two existing datasets (DisTEMIST for diseases and the newly-released DrugTEMIST for medications), as well as a new, smaller dataset of cardiology clinical cases annotated using the same guidelines.

Participants are provided DisTEMIST and DrugTEMIST as training data to use as they see fit (1,000 documents, with the original partitions splitting them into 750 for training and 250 for testing). The cardiology clinical cases (cardioccc) are meant to be used as a development or validation set (258 documents), although participants are encourage to experiment with the documents and annotations as they see fit. The evaluation will be done using a different collection of cardiology clinical cases (250).

MultiCardioNER proposes two tracks:

- Track 1: Spanish adaptation of disease recognition systems to the cardiology domain.- Track 2: Multilingual (Spanish, English and Italian) adaptation of medication recognition systems to the cardiology domain.

Please read the README file attached for more information on folder structure and file format.

MultiCardioNER was developed by the Barcelona Supercomputing Center's NLP for Biomedical Information Analysis and used as part of BioASQ 2024. For more information on the corpus, annotation scheme and task in general, please visit: https://temu.bsc.es/multicardioner. This task is promoted by Spanish and European projects such as DataTools4Heart, AI4HF, BARITONE and AI4ProfHealth.

UPDATE MAY 2ND 2024: A new version has been released containing the texts for the test and background set in English, Spanish and Italian for both tasks. The test data is mixed with the background set, so participants must create predictions for all documents, although they will only be evaluated on the documents belonging to the test set. After the evaluation period is over, we will release the test set and its Gold Standard annotations separately, as well as provide more details about the background set documents.

Resources



MultiCardioNER website

BioASQ website


License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Contact

If you have any questions or suggestions, please contact us at:

- Salvador Lima-López (<salvador [dot] limalopez [at] gmail [dot] com>)- Martin Krallinger (<krallinger [dot] martin [at] gmail [dot] com>)

Additional resources and corpora

If you are interested in MultiCardioNER, you might want to check out these corpora and resources:



DisTEMIST (Corpus of disease mentions and normalization to SNOMED CT)

MedProcNER (Corpus of clinical procedure mentions and normalization to SNOMED CT)

SympTEMIST (Corpus of clinical findings and normalization to SNOMED CT)

PharmaCoNER (Corpus of medications, drugs, chemical substances, genes, proteins and vaccine mentions and normalization)

MEDDOPROF (Corpus of mentions of professions, occupations and working status and normalization)

MEDDOPLACE (Corpus of mentions of place-related entity mentions, including departments, nationalities or patient movements etc.. and normalization)

MEDDOCAN (Corpus of mentions of Personal Health Identifiers (PHI))

CANTEMIST (Corpus of cancer tumor morphology mentions and normalization)

CodiESP (Corpus of clinical case reportes with assigned clinical codes from ICD10, Spanish version)

LivingNER (Corpus of mentions of species, including human/family members, pathogens, food, etc.. and normalization to NCBI Taxonomy)

SPACCC-POS (Corpus of clinical case reports in Spanish annotated with POS-tags)

SPACCC-TOKEN (Corpus of clinical case reports in Spanish annotated with token-tags (word mention boundaries))

SPACCC-SPLIT (Corpus of clinical case reports in Spanish annotated with sentence boundary-tags)

MESINESP-2 (Corpus of manually indexed records with DeCS /MeSH terms comprising scientific literature abstracts, clinical trials, and patent abstracts)